Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression
Phase 2
Not yet recruiting
- Conditions
- SARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2COVID 19 DiseaseMild to Moderate COVID 19 DiseaseInfectious Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- 60P Australia Pty Ltd
- Target Recruit Count
- 148
- Registration Number
- NCT05947812
News
No news found